[1]洪卓民,罗向霞,曾敏,等.近视性屈光不正和眼生物测量参数与糖尿病视网膜病变相关性研究进展[J].眼科新进展,2023,43(7):571-574.[doi:10.13389/j.cnki.rao.2023.0115]
　HONG Zhuomin,LUO Xiangxia,ZENG Min,et al.Advances in the correlation between myopic ametropia and related ocular biometric parameters and diabetic retinopathy[J].Recent Advances in Ophthalmology,2023,43(7):571-574.[doi:10.13389/j.cnki.rao.2023.0115]
点击复制

近视性屈光不正和眼生物测量参数与糖尿病视网膜病变相关性研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
43卷
期数:
2023年7期
页码:
571-574
栏目:
文献综述
出版日期:
2023-07-05

文章信息/Info

Title:
Advances in the correlation between myopic ametropia and related ocular biometric parameters and diabetic retinopathy
作者:
洪卓民; 罗向霞; 曾敏; 杨芮; 吴成亮
730000　甘肃省兰州市，甘肃中医药大学中医临床学院（洪卓民，曾敏，杨芮，吴成亮）；730050　甘肃省兰州市，甘肃省中医院科研处（罗向霞）
Author(s):
HONG Zhuomin1; LUO Xiangxia2; ZENG Min1; YANG Rui1; WU Chengliang1
1.Clinical College of Traditional Chinese Medicine,Gansu University of Tranditional Chinese Medicine，Lanzhou 730000,Gansu Province,China
2.Scientific Research Department of Gansu Provincial Hospital of Tranditional Chinese Medicine,Lanzhou 730050,Gansu Province,China
关键词:
糖尿病视网膜病变; 近视性屈光不正; 眼轴长度
Keywords:
diabetic retinopathy;  myopic ametropia;  axial length
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2023.0115
文献标志码:
A
摘要:
糖尿病视网膜病变（DR）是导致患者视力损害和失明的主要原因之一。已有研究表明，近视和随近视增长的眼轴长度（AL）可能是防止DR发生发展的保护因素，但研究结果并不一致，且尚不清楚起保护作用的是哪种屈光参数。本文通过回顾近年来文献对近视性屈光不正状态、AL、前房深度、角膜曲率、晶状体度数等相关眼生物测量参数与DR相关性的研究进展和可能的保护机制作一综述。
Abstract:
Diabetic retinopathy (DR) is one of the main factors causing visual impairment and blindness in patients.Previous studies have shown that myopia and the axial length that increases with myopia may prevent the occurrence and development of DR,but the results are not consistent,and it is not clear which refractive parameters play a protective role.This paper reviews the advances in the correlation between DR and ocular biometric parameters,including myopic ametropia,axial length,anterior chamber depth,corneal curvature,and lens power,and the possible protective mechanism.

参考文献/References:

［1］　TONNIES T,RATHMANN W,HOYER A,BRINKS R,KUSS O.Quantifying the underestimation of projected global diabetes prevalence by the international diabetes federation (IDF) diabetes atlas［J］.BMJ Open Diabetes Res Care,2021,9(1):e002122.
［2］　FRAGIOTTA S,PINAZO-DURAN M D,SCUDERI G.Understanding neurodegeneration from a clinical and therapeutic perspective in early diabetic retinopathy［J］.Nutrients,2022,14(4):792.
［3］　OSHITARI T.Neurovascular impairment and therapeutic strategies in diabetic retinopathy［J］.Int J Environ Res Public Health,2021,19(1):439.
［4］　WANG W,LO A C Y.Diabetic retinopathy:pathophysiology and treatments［J］.Int J Mol Sci,2018,19(6):1816.
［5］　JIN H,ZHU B,LIU X,JIN J,ZOU H.Metabolic characterization of diabetic retinopathy:an (1)H-NMR-based metabolomic approach using human aqueous humor［J］.J Pharm Biomed Anal,2019,174:414-421.
［6］　TAKELE M B,BONEYA D J,ALEMU H A,TSEGAYE T B,BIRHANU M Y,ALEMS S,et al.Retinopathy among adult diabetics and its predictors in northwest ethiopia［J］.J Diabetes Res,2022,2022:1362144.
［7］　DASH S,CHOUGULE A,MOHANTY S.Correlation of albuminuria and diabetic retinopathy in type-II diabetes mellitus patients［J］.Cureus,2022,14(2):e21927.
［8］　WEN X,LI Z,XIAO J,LIU X,ZHANG Y,LAN Y.Association of myopia with microvascular alterations in patients with type 2 diabetes:an optical coherence tomography angiography study［J］.Front Med (Lausanne),2021,8:715074.
［9］　WANG W,CHEN Y,XIONG K,GONG X,LIANG X,HUANG W.Longitudinal associations of ocular biometric parameters with onset and progression of diabetic retinopathy in chinese adults with type 2 diabetes mellitus［J］.Br J Ophthalmol,2023,107(5):738-742.
［10］　HAMATI J N,DAS A V,PRASHANTHI G S,BEHERA U C,NARAYANAN R,RANI P K.Factors protecting against diabetic retinopathy in a geriatric indian cohort［J］.Indian J Ophthalmol,2021,69(11):3167-3172.
［11］　HAINSWORTH D P,GAO X,BEBU I,DAS A,OLMOS D K L,BARKMEIER A J,et al.Refractive error and retinopathy outcomes in type 1 diabetes:the diabetes control and complications trial/epidemiology of diabetes interventions and complications study［J］.Ophthalmology,2021,128(4):554-560.
［12］　BIKBOV M M,KAZAKBAEVA G M,GILMANSHIN T R,ZAINULLIN R M,ARSLANGAREEVA L L,SALAVATOVA V F,et al.Axial length and its associations in a russian population:the ural eye and medical study［J］.PLoS One,2019,14(2):e0211186.
［13］　CHAO D L,LIN S C,CHEN R,LIN S C.Myopia is inversely associated with the prevalence of diabetic retinopathy in the south korean population［J］.Am J Ophthalmol,2016,172:39-44.
［14］　LIN Z,LI D,ZHAI G,WANG Y,WEN L,DING X X,et al.High myopia is protective against diabetic retinopathy via thinning retinal vein:a report from fushun diabetic retinopathy cohort study (FS-DIRECT)［J］.Diab Vasc Dis Res,2020,17(4):1479164120940988.
［15］　BAZZAZI N,AKBARZADEH S,YAVARIKIA M,POOROLAJAL J,FOULADI D F.High myopla and dlabetic retinopathy:a contralateral eye study in diabetic patients with high myopic anisometropia.［J］.Retina,2017,37(7):1270-1276.
［16］　林仲,温良,翟刚,王禹,李东,丁晓霞,等.近视与糖尿病视网膜病变的相关性［J］.中华眼视光学与视觉科学杂志，2020,22(9):702-706.
LIN Z,WEN L,ZHAI G,WANG Y,LI D,DING X X,et al.Study of the association between myopia and diabetic retinopathy.［J］.Chin J Optom Ophthalmol Vis Sci,2020,22(9):702-706.
［17］　THAKUR S,VERKICHARLA P K,KAMMARI P,RANI P K.Does myopia decrease the risk of diabetic retinopathy in both type-1 and type-2 diabetes mellitus?［J］.Indian J Ophthalmol,2021,69(11):3178-3183.
［18］　ADLAKHA N,KAUR M,SINGH A A,SHARMA V.Calculation of intraocular lens power and to determine the relationship between ocular biometry and severity of diabetic retinopathy in patients with type II diabetes mellitus［J］.Indian J Ophthalmol,2021,69(11):3190-3193.
［19］　KIM D Y,SONG J H,KIM Y J,LEE J Y,KIM J G,YOON Y H,et al.Asymmetric diabetic retinopathy progression in patients with axial anisometropia［J］.Retina,2018,38(9):1809-1815.
［20］　HE J,XU X,ZHU J,ZHU B,ZHANG B,LU L,et al.Lens power,axial length-to-corneal radius ratio,and association with diabetic retinopathy in the adult population with type 2 diabetes［J］.Ophthalmology,2017,124(3):326-335.
［21］　WANG L H,LIU S,WANG W,HE M,MO Z Y,GONG X,et al.Association between ocular biometrical parameters and diabetic retinopathy in chinese adults with type 2 diabetes mellitus［J］.Acta Ophthalmol,2021,99(5):e661-e668.
［22］　WANG Q,WANG Y X,WU S L,CHEN S H,YAN Y N,YANG M C,et al.Ocular axial length and diabetic retinopathy:the kailuan eye study［J］.Invest Ophthalmol Vis Sci,2019,60(10):3689-3695.
［23］　MAN R E K,GAN A T L,GUPTA P,FENWICK E K,SABANAYAGAM C,TAN N Y Q,et al.Is myopia associated with the incidence and progression of diabetic retinopathy?［J］.Am J Ophthalmol,2019,208:226-233.
［24］　BIKBOV M M,GILMANSHIN T R,ZAINULLIN R M,KAZAKBAEVA G M,NURIYEV I F,ZAYNETDINOV A F,et al.Prevalence and associated factors of diabetic retinopathy in a russian population.The ural eye and medical study［J］.Diabetes Metab Syndr Obes,2021,14:4723-4734.
［25］　CHENG T,DENG J,XU X,ZHANG B,WANG J,XIONG S,et al.Prevalence of fundus tessellation and its associated factors in chinese children and adolescents with high myopia［J］.Acta Ophthalmol,2021,99(8):e1524-e1533.
［26］　HAARMAN A E G,TEDJA M S,BRUSSEE C,ENTHOVEN C A,VAN R J A,VINGERLING J R,et al.Prevalence of myopic macular features in dutch individuals of european ancestry with high myopia［J］.JAMA Ophthalmol,2022,140(2):115-123.
［27］　RUIZ-MEDRANO J,MONTERO J A,FLORES-MORENO I,ARIAS L,GARCIA-LAYANA A,RUIZ-MORENO J M.Myopic maculopathy:current status and proposal for a new classification and grading system (ATN)［J］.Prog Retin Eye Res,2019,69:80-115.
［28］　GUO Y,LIU L,ZHENG D,DUAN J,WANG Y,JONAS J B,et al.Prevalence and associations of fundus tessellation among junior students from greater beijing［J］.Invest Ophthalmol Vis Sci,2019,60(12):4033-4040.
［29］　TAN N Y Q,THAM Y C,DING Y,YASUDA M,SABANAYAGAM C,SAW S M,et al.Associations of peripapillary atrophy and fundus tessellation with diabetic retinopathy［J］.Ophthalmol Retina,2018,2(6):574-581.
［30］　LIN Q,JIA Y,LI T,WANG S,XU X,XU Y,et al.Optic disc morphology and peripapillary atrophic changes in diabetic children and adults without diabetic retinopathy or visual impairment［J］.Acta Ophthalmol,2022,100(1):e157-e166.
［31］　JONAS J B,WANG Y X,DONG L,GUO Y,PANDA-JONAS S.Advances in myopia research anatomical findings in highly myopic eyes［J］.Eye Vis (Lond),2020,7:45.
［32］　UCAK T,ICEL E,YILMAZ H,KARAKURT Y,TASLI G,UGURLU A,et al.Alterations in optical coherence tomography angiography findings in patients with high myopia［J］.Eye (Lond),2020,34(6):1129-1135.
［33］　SAMARA W A,SHAHLAEE A,ADAM M K,KHAN M A,CHIANG A,MAGUIRE J L,et al.Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity［J］.Ophthalmology,2017,124(2):235-244.
［34］　SUN Z,TANG F,WONG R,LOK J,SZETO S K H,CHAN J C K,et al.OCT angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema:a prospective study［J］.Ophthalmology,2019,126(12):1675-1684.
［35］　WANG X Q,ZENG L Z,CHEN M,LIU L Q.A meta-analysis of alterations in the retina and choroid in high myopia assessed by optical coherence tomography angiography［J］.Ophthalmic Res,2021,64(6):928-937.
［36］　LI M,YANG Y,JIANG H,GREGORI G,ROISMAN L,ZHENG F,et al.Retinal microvascular network and microcirculation assessments in high myopia［J］.Am J Ophthalmol,2017,174:56-67.
［37］　MAN R E,LAMOUREUX E L,TAOUK Y,XIE J,SASONGKO M B,BEST W J,et al.Axial length,retinal function,and oxygen consumption:a potential mechanism for a lower risk of diabetic retinopathy in longer eyes［J］.Invest Ophthalmol Vis Sci,2013,54(12):7691-7698.
［38］　XIONG K,WANG W,GONG X,JI Y,GUO X,YUAN M,et al.Influence of high myopia on choriocapillaris perfusion and choroidal thickness in diabetic patients without diabetic retinopathy［J］.Retina,2022,42(6):1077-1084.
［39］　HANYUDA A,TORII H,HAYASHI K,UCHIDA A,MORI K,YOTSUKURA E,et al.Relationship of choroidal thickness and axial length with posterior vitreous detachment in patients with high myopia［J］.Sci Rep,2022,12(1):4093.
［40］　HAYASHI K,MANABE S I,HIRATA A,YOSHIMURA K.Posterior vitreous detachment in highly myopic patients［J］.Invest Ophthalmol Vis Sci,2020,61(4):33.
［41］　ANDERSON W,PIGGOTT K,BAO Y K,PHAM H,KAVALI S,RAJAGOPAL R.Complete posterior vitreous detachment reduces the need for treatment of diabetic macular edema［J］.Ophthalmic Surg Lasers Imaging Retina,2019,50(11):e266-e273.
［42］　GELLA L,RAMAN R,KULOTHUNGAN V,SHARMA T.Prevalence of posterior vitreous detachment in the population with type II diabetes mellitus and its effect on diabetic retinopathy:sankara nethralaya diabetic retinopathy epidemiology and molecular genetic study SN-DREAMS report No.23［J］.Jpn J Ophthalmol,2012,56(3):262-267.
［43］　HAYASHI K,SATO T,MANABE S I,HIRATA A,YOSHIMURA K.Posterior vitreous detachment in patients with diabetes mellitus［J］.Jpn J Ophthalmol,2020,64(2):187-195.
［44］　LIU H,MA Y,XU H C,HUANG L Y,ZHAI L Y,ZHANG X R.Updates on the management of ocular vasculopathies with vegf inhibitor conbercept［J］.Curr Eye Res,2020,45(12):1467-1476.
［45］　HONG F,YANG D Y,LI L,ZHENG Y F,WANG X J,GUO S R N,et al.Relationship between aqueous humor levels of cytokines and axial length in patients with diabetic retinopathy［J］.Asia Pac J Ophthalmol (Phila),2020,9(2):149-155.
［46］　YAFAI Y,IANDIEV I,LANGE J,YANG X M,WIEDEMANN P,BRINGMANN A,et al.Basic fibroblast growth factor contributes to a shift in the angioregulatory activity of retinal glial (Muller) cells［J］.PLoS One,2013,8(7):e68773.
［47］　FAN J,SHEN W,LEE S R,MATHAI A E,ZHANG R,XU G,et al.Targeting the notch and tgf-beta signaling pathways to prevent retinal fibrosis in vitro and in vivo［J］.Theranostics,2020,10(18):7956-7973.
［48］　ZHU D,YANG D Y,GUO Y Y,ZHENG Y F,LI J L,WANG B,et al.Intracameral interleukin 1beta,6,8,10,12p,tumor necrosis factor alpha and vascular endothelial growth factor and axial length in patients with cataract［J］.PLoS One,2015,10(2):e0117777.
［49］　MUHIDDIN H S,KAMARUDDIN M I,ICHSAN A M,BUDU.Vitreous and serum concentrations of vascular endothelial growth factor and platelet-derived growth factor in proliferative diabetic retinopathy［J］.Clin Ophthalmol,2020,14:1547-1552.
［50］　王坤,万光明,徐亚娟,梁申芝.糖尿病合并高度近视患者玻璃体中VEGF和EPO的表达及意义［J］.眼科新进展，2014，34(5)：445-447.
WANG K,WAN G M,XU Y J,LIANG S Z.Expression and significance of vegf and epo in vitreous body of diabetes mellitus with high myopia［J］.Rec Adv Ophthalmol,2014,34(5):445-447.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.

备注/Memo

备注/Memo:
国家自然科学基金项目（编号：81960888）；甘肃省重点研发计划（编号：20YF3FA019）
更新日期/Last Update: 2023-07-05